University of Florida
Gainesville, Florida, 32610, United States
NCT Number: NCT03385577
This study will test the feasibility and acceptability of a yoga program for women with gynecologic, gastrointestinal (GI), or thoracic malignancies. This study will pilot an integrative yoga intervention that combines Western psychotherapeutic approaches with classic yogic philosophy to reduce emotional distress among women undergoing treatment for gynecologic, gastrointestinal (GI), or thoracic cancer and provide a comprehensive approach to stress management across the cancer care continuum.
Looking for future studies?
Notify Me18 year–90 year
Female
Interventional
Not applicable
Gainesville, Florida, 32610, United States
Gynecologic cancers are malignancies of the female reproductive tract that affect over 70,000 women per year. Treatments for gynecologic cancer often result in numerous physical and emotional side effects that affect long-term adjustment, such as anxiety, depression, low self-esteem, sexual dysfunction, difficulties with fertility, and surgically-induced menopause. Even when initial treatments are successful, gynecologic cancers have a high recurrence rate that can reach nearly 80% among those with ovarian cancer. Fear of Cancer Recurrence (FCR) is described as one of the largest unmet psychological needs among gynecologic cancer patients and is associated with psychological distress, increased health care utilization, and functional impairment. Few studies have examined interventions designed to manage symptoms of FCR, which leaves a significant gap in the literature regarding treatment of this prominent psychosocial problem. Cancer patients report growing use of integrative medicine therapies (e.g., yoga, acupuncture, massage) to manage unmet physical and emotional needs related to their disease and treatment. The current study will take advantage of this trend in supportive oncology to investigate the feasibility and acceptability of a novel intervention program created specially to address FCR among women with gynecologic cancer. Patients will be recruited from the UF Health/Shands Hospital Gynecology Oncology Clinic and Medical Oncology clinic and invited to participate in a 10-week, manualized, small group yoga course. Psychoeducation modules, meditation training, and gentle yoga poses will be integrated into a comprehensive program focused on managing the psychosocial concerns of newly diagnosed gynecologic cancer patients. Findings from this research will contribute to the existing literature on FCR and knowledge regarding the use of integrative medicine techniques for addressing unmet psychological needs among gynecologic cancer patients. If the intervention is deemed feasible and acceptable, future research may explore ways in which this manualized yoga program compares to other psychosocial treatments for managing FCR and other forms of emotional distress in women with cancer.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
'Stilling the waters,' the prominent theme of this program, is drawn from the core principle in yogic philosophy. It uses breath techniques and physical postures to cultivate inner peace and an ability to live in the present moment. The emphasis on stilling the fluctuations of uncertainty is a direct allusion to the intrusive and inherently unknown future, which characterizes the core experience of Fear of Cancer Recurrence (FCR). This is especially true among gynecologic, gastrointestinal (GI), or thoracic cancer patients for whom the likelihood of recurrence is quite high. An additional motif throughout the program is the lotus flower. The symbolic importance of the lotus in yogic culture is due to its requiring thick muddy waters for ideal growth. The metaphor of cancer as the muddy waters will be used to cultivate benefit-finding and acceptance regarding the mental and physical challenges participants endured during their initial diagnosis and treatment.
Time frame: Pre-Intervention (Baseline) to Post-Intervention (Ten Weeks After Baseline)
Patients will complete the majority (80%) of study activities as measured by five empirically-driven indicators of feasibility.
Time frame: Pre-Intervention (Baseline) to Post-Intervention (Ten Weeks After Baseline)
Patients will complete the majority (80%) of study activities as measured by five empirically-driven indicators of feasibility.
Time frame: Pre-Intervention (Baseline) to Post-Intervention (Ten Weeks After Baseline)
Patients will complete the majority (80%) of study activities as measured by five empirically-driven indicators of feasibility.
Time frame: Pre-Intervention (Baseline) to Post-Intervention (Ten Weeks After Baseline)
Patients will complete the majority (80%) of study activities as measured by five empirically-driven indicators of feasibility.
Time frame: Pre-Intervention (Baseline) to Post-Intervention (Ten Weeks After Baseline)
Patients will complete the majority (80%) of study activities as measured by five empirically-driven indicators of feasibility
Time frame: Pre-Intervention (Baseline) to Post-Intervention (Ten Weeks After Baseline)
The majority of patients (80%) will rate five key dimensions of the intervention on a Likert scale as "Very" or "Extremely" acceptable.
Time frame: Pre-Intervention (Baseline) to Post-Intervention (Ten Weeks After Baseline)
The majority of patients (80%) will rate five key dimensions of the intervention on a Likert scale as "Very" or "Extremely" acceptable.
Time frame: Pre-Intervention (Baseline) to Post-Intervention (Ten Weeks After Baseline)
The majority of patients (80%) will rate five key dimensions of the intervention on a Likert scale as "Very" or "Extremely" acceptable.
Time frame: Pre-Intervention (Baseline) to Post-Intervention (Ten Weeks After Baseline)
The majority of patients (80%) will rate five key dimensions of the intervention on a Likert scale as "Very" or "Extremely" acceptable.
Time frame: Pre-Intervention (Baseline) to Post-Intervention (Ten Weeks After Baseline)
The majority of patients (80%) will rate five key dimensions of the intervention on a Likert scale as "Very" or "Extremely" acceptable.
Time frame: Pre-Intervention (Baseline) to Post-Intervention (Ten Weeks After Baseline)
This measure will access participants' Fear of Cancer Recurrence (FCR), which includes cognitive, behavioral, and emotional experiences related to worries that their cancer will return.
Time frame: Pre-Intervention (Baseline) to Post-Intervention (Ten Weeks After Baseline)
The Distress Thermometer will be used to assess cancer-related distress. This measure is designed to assess self-efficacy regarding distress and symptom management while facing a cancer diagnosis. Domains assessed include maintenance of activity and independence, seeking and understanding medical information, stress management, coping with treatment side effects, maintaining a positive attitude, engaging in emotion regulation, and seeking support.
Time frame: Pre-Intervention (Baseline) to Post-Intervention (Ten Weeks After Baseline)
Anxiety will be assessed with the State Trait Anxiety Inventory (STAI) Assesses state /trait anxiety symptoms on 4 pt. likert scale. Medium: May indicate anxiety disorder
Time frame: Pre-Intervention (Baseline) to Post-Intervention (Ten Weeks After Baseline)
Depressive symptoms will be assessed with the Beck Depression Inventory - Second Edition (BDI-2) - high score Suicidal Behavior
University of Florida
Other
Feasibility, Acceptability, and Efficacy of a Yoga Intervention for Distress in Women With Gynecologic, Gastrointestinal, or Thoracic Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03850912
Digestive System Diseases, Digestive System Neoplasms
Portland, Maine, United States
View Trial DetailsNCT03245788
Bone Marrow Transplant, Breast Cancer
Palo Alto, California, United States
View Trial DetailsNCT01833637
Breast Cancer, Breast Diseases
Chicago, Illinois, United States
View Trial DetailsNCT06633224
Cancer, Digestive System Diseases
San Francisco, California, United States
View Trial Details